Technology-based self-care methods of improving antiretroviral adherence: a systematic review

Parya Saberi, Mallory O Johnson, Parya Saberi, Mallory O Johnson

Abstract

Background: As HIV infection has shifted to a chronic condition, self-care practices have emerged as an important topic for HIV-positive individuals in maintaining an optimal level of health. Self-care refers to activities that patients undertake to maintain and improve health, such as strategies to achieve and maintain high levels of antiretroviral adherence.

Methodology/principal findings: Technology-based methods are increasingly used to enhance antiretroviral adherence; therefore, we systematically reviewed the literature to examine technology-based self-care methods that HIV-positive individuals utilize to improve adherence. Seven electronic databases were searched from 1/1/1980 through 12/31/2010. We included quantitative and qualitative studies. Among quantitative studies, the primary outcomes included ARV adherence, viral load, and CD4+ cell count and secondary outcomes consisted of quality of life, adverse effects, and feasibility/acceptability data. For qualitative/descriptive studies, interview themes, reports of use, and perceptions of use were summarized. Thirty-six publications were included (24 quantitative and 12 qualitative/descriptive). Studies with exclusive utilization of medication reminder devices demonstrated less evidence of enhancing adherence in comparison to multi-component methods.

Conclusions/significance: This systematic review offers support for self-care technology-based approaches that may result in improved antiretroviral adherence. There was a clear pattern of results that favored individually-tailored, multi-function technologies, which allowed for periodic communication with health care providers rather than sole reliance on electronic reminder devices.

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Figure 1. Selection process for study inclusion.
Figure 1. Selection process for study inclusion.

References

    1. Anastasio C, McMahan T, Daniels A, Nicholas PK, Paul-Simon A. Self-care burden in women with human immunodeficiency virus. J Assoc Nurses AIDS Care. 1995;6:31–42.
    1. Barroso J. Self-care activities of long-term survivors of acquired immunodeficiency syndrome. Holist Nurs Pract. 1995;10:44–53.
    1. Sowell RL, Moneyham L, Guillory J, Seals B, Cohen L, et al. Self-care activities of women infected with human immunodeficiency virus. Holist Nurs Pract. 1997;11:18–26.
    1. Holzemer WL, Henry SB, Reilly CA. Assessing and managing pain in AIDS care: the patient perspective. J Assoc Nurses AIDS Care. 1998;9:22–30.
    1. Henry SB, Holzemer WL, Weaver K, Stotts N. Quality of life and self-care management strategies of PLWAs with chronic diarrhea. J Assoc Nurses AIDS Care. 1999;10:46–54.
    1. Chou FY, Holzemer WL, Portillo CJ, Slaughter R. Self-care strategies and sources of information for HIV/AIDS symptom management. Nurs Res. 2004;53:332–339.
    1. Levin LS, Katz A, Holst E. Self-care: Lay initiatives in health. New York: Provost; 1979.
    1. Levin LS. Self-care–new challenge to individual health. J Am Coll Health Assoc. 1979;28:117–120.
    1. Levin LS, Idler EL. Self-care in health. Annu Rev Public Health. 1983;4:181–201.
    1. Dean K. Self-care responses to illness: a selected review. Soc Sci Med A. 1981;15:673–687.
    1. Riegel B, Dickson VV. A situation-specific theory of heart failure self-care. J Cardiovasc Nurs. 2008;23:190–196.
    1. Chou FY, Holzemer WL. Linking HIV/AIDS clients' self-care with outcomes. J Assoc Nurses AIDS Care. 2004;15:58–67.
    1. Holzemer WL, Corless IB, Nokes KM, Turner JG, Brown MA, et al. Predictors of self-reported adherence in persons living with HIV disease. AIDS Patient Care and STDs. 1999;13:185–197.
    1. Paterson DL, Swindells S, Mohr J, Brester M, Vergis EN, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med. 2000;133:21–30.
    1. Chesney MA, Ickovics J, Hecht FM, Sikipa G, Rabkin J. Adherence: a necessity for successful HIV combination therapy. AIDS. 1999;13(Suppl A):S271–278.
    1. Mannheimer S, Friedland G, Matts J, Child C, Chesney M. The consistency of adherence to antiretroviral therapy predicts biologic outcomes for human immunodeficiency virus-infected persons in clinical trials. Clin Infect Dis. 2002;34:1115–1121.
    1. Little SJ, Holte S, Routy JP, Daar ES, Markowitz M, et al. Antiretroviral-drug resistance among patients recently infected with HIV. N Engl J Med. 2002;347:385–394.
    1. Grant RM, Hecht FM, Warmerdam M, Liu L, Liegler T, et al. Time trends in primary HIV-1 drug resistance among recently infected persons. JAMA. 2002;288:181–188.
    1. Simon V, Vanderhoeven J, Hurley A, Ramratnam B, Louie M, et al. Evolving patterns of HIV-1 resistance to antiretroviral agents in newly infected individuals. AIDS. 2002;16:1511–1519.
    1. Blower SM, Aschenbach AN, Gershengorn HB, Kahn JO. Predicting the unpredictable: transmission of drug-resistant HIV. Nat Med. 2001;7:1016–1020.
    1. Gifford AL, Bormann JE, Shively MJ, Wright BC, Richman DD, et al. Predictors of self-reported adherence and plasma HIV concentrations in patients on multidrug antiretroviral regimens. J Acquir Immune Defic Syndr. 2000;23:386–395.
    1. Moatti JP, Carrieri MP, Spire B, Gastaut JA, Cassuto JP, et al. Adherence to HAART in French HIV-infected injecting drug users: the contribution of buprenorphine drug maintenance treatment. The Manif 2000 study group. AIDS. 2000;14:151–155.
    1. Heckman BD, Catz SL, Heckman TG, Miller JG, Kalichman SC. Adherence to antiretroviral therapy in rural persons living with HIV disease in the United States. AIDS Care. 2004;16:219–230.
    1. Bangsberg DR, Hecht FM, Charlebois ED, Zolopa AR, Holodniy M, et al. Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. AIDS. 2000;14:357–366.
    1. Bartlett JA. Addressing the challenges of adherence. J Acquir Immune Defic Syndr. 2002;29(Suppl 1):S2–10.
    1. Martin-Fernandez J, Escobar-Rodriguez I, Campo-Angora M, Rubio-Garcia R. Evaluation of adherence to highly active antiretroviral therapy. Arch Intern Med. 2001;161:2739–2740.
    1. Nieuwkerk PT, Sprangers MA, Burger DM, Hoetelmans RM, Hugen PW, et al. Limited patient adherence to highly active antiretroviral therapy for HIV-1 infection in an observational cohort study. Arch Intern Med. 2001;161:1962–1968.
    1. Mills EJ, Nachega JB, Bangsberg DR, Singh S, Rachlis B, et al. Adherence to HAART: a systematic review of developed and developing nation patient-reported barriers and facilitators. PLoS Med. 2006;3:e438.
    1. Dybul M, Fauci AS, Bartletti JG, Kaplan JE, Pau AK. Services DoHaH., editor. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. 2011. Panel on Antiretroviral Guidelines for Adults and Adolescents.
    1. Poppa A, Davidson O, Deutsch J, Godfrey D, Fisher M, et al. British HIV Association (BHIVA)/British Association for Sexual Health and HIV (BASHH) guidelines on provision of adherence support to individuals receiving antiretroviral therapy (2003). HIV Med. 2004;5(Suppl 2):46–60.
    1. Organization WH, editor. Geneva: 2003. Adherence to Long-Term Therapies: Evidence for Action.
    1. Wise J, Operario D. Use of electronic reminder devices to improve adherence to antiretroviral therapy: a systematic review. AIDS Patient Care STDS. 2008;22:495–504.
    1. Simoni JM, Pearson CR, Pantalone DW, Marks G, Crepaz N. Efficacy of interventions in improving highly active antiretroviral therapy adherence and HIV-1 RNA viral load. A meta-analytic review of randomized controlled trials. J Acquir Immune Defic Syndr. 2006;43(Suppl 1):S23–35.
    1. Lefebvre C, Manheimer E, Glanville J. Higgins JPT, Green S, editors. Chapter 6: Searching for studies. 2011. Cochrane Handbook for Systematic Reviews of Interventions Version 510 (updated March 2011): The Cochrane Collaboration.
    1. Andrade AS, McGruder HF, Wu AW, Celano SA, Skolasky RL, Jr, et al. A programmable prompting device improves adherence to highly active antiretroviral therapy in HIV-infected subjects with memory impairment. Clin Infect Dis. 2005;41:875–882.
    1. Fairley CK, Levy R, Rayner CR, Allardice K, Costello K, et al. Randomized trial of an adherence programme for clients with HIV. Int J STD AIDS. 2003;14:805–809.
    1. Golin CE, Liu H, Hays RD, Miller LG, Beck CK, et al. A prospective study of predictors of adherence to combination antiretroviral medication. J Gen Intern Med. 2002;17:756–765.
    1. Iroha E, Esezobor CI, Ezeaka C, Temiye EO, Akinsulie A. Adherence to antiretroviral therapy among HIV-infected children attending a donor-funded clinic at a tertiary hospital in Nigeria. Ajar-African Journal of AIDS Research. 2010;9:25–30.
    1. Kalichman SC, Cain D, Cherry C, Pope H, Eaton L, et al. Internet use among people living with HIV/AIDS: coping and health-related correlates. AIDS Patient Care STDS. 2005;19:439–448.
    1. Kalichman SC, Rompa D, DiFonzo K, Simpson D, Austin J, et al. HIV treatment adherence in women living with HIV/AIDS: research based on the Information-Motivation-Behavioral Skills model of health behavior. J Assoc Nurses AIDS Care. 2001;12:58–67.
    1. Levy RW, Rayner CR, Fairley CK, Kong DC, Mijch A, et al. Multidisciplinary HIV adherence intervention: a randomized study. AIDS Patient Care and STDs. 2004;18:728–735.
    1. Lyon ME, Trexler C, Akpan-Townsend C, Pao M, Selden K, et al. A family group approach to increasing adherence to therapy in HIV-infected youths: results of a pilot project. AIDS Patient Care STDS. 2003;17:299–308.
    1. Mannheimer SB, Morse E, Matts JP, Andrews L, Child C, et al. Sustained benefit from a long-term antiretroviral adherence intervention. Results of a large randomized clinical trial. Journal of acquired immune deficiency syndromes (1999) 2006;43(Suppl 1):S41–47.
    1. Murphy DA, Lu MC, Martin D, Hoffman D, Marelich WD. Results of a pilot intervention trial to improve antiretroviral adherence among HIV-positive patients. The Journal of the Association of Nurses in AIDS Care : JANAC. 2002;13:57–69.
    1. Murphy DA, Marelich WD, Rappaport NB, Hoffman D, Farthing C. Results of an Antiretroviral Adherence Intervention: STAR (Staying Healthy: Taking Antiretrovirals Regularly). J Int Assoc Physicians AIDS Care (Chic) 2007;6:113–124.
    1. Safren SA, Hendriksen ES, Desousa N, Boswell SL, Mayer KH. Use of an on-line pager system to increase adherence to antiretroviral medications. AIDS Care. 2003;15:787–793.
    1. Samet JH, Horton NJ, Meli S, Dukes K, Tripps T, et al. A randomized controlled trial to enhance antiretroviral therapy adherence in patients with a history of alcohol problems. Antivir Ther. 2005;10:83–93.
    1. Samet JH, Libman H, Steger KA, Dhawan RK, Chen J, et al. Compliance with zidovudine therapy in patients infected with human immunodeficiency virus, type 1: a cross-sectional study in a municipal hospital clinic. Am J Med. 1992;92:495–502.
    1. Simoni JM, Chen WT, Huh D, Fredriksen-Goldsen KI, Pearson C, et al. A Preliminary Randomized Controlled Trial of a Nurse-Delivered Medication Adherence Intervention Among HIV-Positive Outpatients Initiating Antiretroviral Therapy in Beijing, China. AIDS Behav 2010
    1. Simoni JM, Huh D, Frick PA, Pearson CR, Andrasik MP, et al. Peer support and pager messaging to promote antiretroviral modifying therapy in seattle: A randomized controlled trial. Journal of Acquired Immune Deficiency Syndromes. 2009;52:465–473.
    1. Crankshaw T, Corless IB, Giddy J, Nicholas PK, Eichbaum Q, et al. Exploring the patterns of use and the feasibility of using cellular phones for clinic appointment reminders and adherence messages in an antiretroviral treatment clinic, Durban, South Africa. AIDS Patient Care STDS. 2010;24:729–734.
    1. Dunbar PJ, Madigan D, Grohskopf LA, Revere D, Woodward J, et al. A two-way messaging system to enhance antiretroviral adherence. J Am Med Inform Assoc. 2003;10:11–15.
    1. Holzemer WL, Henry SB, Portillo CJ, Miramontes H. The Client Adherence Profiling-Intervention Tailoring (CAP-IT) intervention for enhancing adherence to HIV/AIDS medications: a pilot study. J Assoc Nurses AIDS Care. 2000;11:36–44.
    1. Konkle-Parker DJ, Erlen JA, Dubbert PM. Lessons learned from an HIV adherence pilot study in the Deep South. Patient Educ Couns. 2010;78:91–96.
    1. Powell-Cope GM, White J, Henkelman EJ, Turner BJ. Qualitative and quantitative assessments of HAART adherence of substance-abusing women. AIDS Care. 2003;15:239–249.
    1. Smith SR, Brock TP, Howarth SM. Use of personal digital assistants to deliver education about adherence to antiretroviral medications. J Am Pharm Assoc (2003) 2005;45:625–628.
    1. Wong IY, Lawrence NV, Struthers H, McIntyre J, Friedland GH. Development and assessment of an innovative culturally sensitive educational videotape to improve adherence to highly active antiretroviral therapy in Soweto, South Africa. J Acquir Immune Defic Syndr. 2006;43(Suppl 1):S142–148.
    1. Wu AW, Snyder CF, Huang IC, Skolasky R, McGruder HF, et al. A randomized trial of the impact of a programmable medication reminder device on quality of life in patients with AIDS. AIDS Patient Care STDS. 2006;20:773–781.
    1. Biadgilign S, Deribew A, Amberbir A, Deribe K. Barriers and facilitators to antiretroviral medication adherence among HIV-infected paediatric patients in Ethiopia: A qualitative study. SAHARA J. 2009;6:148–154.
    1. Curioso WH, Kurth AE. Access, use and perceptions regarding Internet, cell phones and PDAs as a means for health promotion for people living with HIV in Peru. BMC Med Inform Decis Mak. 2007;7:24.
    1. Grant E, Logie D, Masura M, Gorman D, Murray SA. Factors facilitating and challenging access and adherence to antiretroviral therapy in a township in the Zambian Copperbelt: a qualitative study. AIDS Care. 2008;20:1155–1160.
    1. Harris LT, Lehavot K, Huh D, Yard S, Andrasik MP, et al. Two-way text messaging for health behavior change among human immunodeficiency virus-positive individuals. Telemed J E Health. 2010;16:1024–1029.
    1. Harvey KM, Carrington D, Duncan J, Figueroa JP, Hirschorn L, et al. Evaluation of adherence to highly active antiretroviral therapy in adults in Jamaica. West Indian Med J. 2008;57:293–297.
    1. Kemppainen JK, Levine RE, Mistal M, Schmidgall D. HAART adherence in culturally diverse patients with HIV/AIDS: a study of male patients from a Veteran's Administration Hospital in northern California. AIDS Patient Care STDS. 2001;15:117–127.
    1. Lewis MP, Colbert A, Erlen J, Meyers M. A qualitative study of persons who are 100% adherent to antiretroviral therapy. AIDS Care. 2006;18:140–148.
    1. Murphy DA, Roberts KJ, Martin DJ, Marelich W, Hoffman D. Barriers to antiretroviral adherence among HIV-infected adults. AIDS Patient Care and STDs. 2000;14:47–58.
    1. Ostrop NJ, Gill MJ. Antiretroviral medication adherence and persistence with respect to adherence tool usage. AIDS Patient Care STDS. 2000;14:351–358.
    1. Ostrop NJ, Hallett KA, Gill MJ. Long-term patient adherence to antiretroviral therapy. Ann Pharmacother. 2000;34:703–709.
    1. Shet A, Arumugam K, Rodrigues R, Rajagopalan N, Shubha K, et al. Designing a mobile phone-based intervention to promote adherence to antiretroviral therapy in South India. AIDS Behav. 2010;14:716–720.
    1. Starks H, Simoni J, Zhao H, Huang B, Fredriksen-Goldsen K, et al. Conceptualizing antiretroviral adherence in Beijing, China. AIDS Care. 2008;20:607–614.
    1. Curioso WH. Evaluation of a computer-based system using cell phones for HIV people in Peru (Cell-POC) (5R01TW007896-03). 2011. Fogarty International Center.
    1. Kahn J. Adherence improvement measure (AIM) system (5RC1MH088341-02). 2011. National Institute Of Mental Health.
    1. Ownby RL. An automated, tailored information application for medication health literacy (5R21MH086491-02). 2011. National Institute Of Mental Health.
    1. Kumar VS. ARemind: a personalized system to remind for adherence (5R44MH080655-03). 2010. National Institute Of Mental Health.
    1. Moore DJ. Personalized text messages to improve antiretroviral treatment (ARV) adherence in hiv+ methamphetamine users (iTAB) ( identifie: NCT01317277). 2011. University of California, San Diego.
    1. Claborn KR. Electronic intervention for HIV medication adherence ( identifier: NCT01291485). 2011. Oklahoma State University Center for Health Sciences.
    1. Horvath KJ. A pilot test of an online HIV medication adherence intervention (5R34MH083549-03). 2011. National Institute Of Mental Health.
    1. Ingersoll KS. Text messaging adherence assessment & intervention tool for rural hiv+ drug users (1R34DA031640-01). 2011. National Institute On Drug Abuse.
    1. Garofalo R. Text messaging intervention to improve art adherence among hiv-positive youth (1R34DA031053-01). 2010. National Institute On Drug Abuse.
    1. Cook RF. Test of a web-based program to improve adherence to HIV/AIDS medications (5RC1DA028505-02). 2010. Office Of The Director, National Institutes Of Health.
    1. UNAIDSUnited Nations, editor. Geneva: 2009. What countries need: investments needed for 2010 targets.
    1. UNAIDSUnited Nations, editor. Geneva: 2009. Towards universal access. Scaling up priority HIV/AIDS interventions in the health sector: progress report 2009.
    1. United Nations General assembly. Political declaration on HIV/AIDS: resolution adopted by the General Assembly 60/262. In: Nations U, editor. New York: 2006.

Source: PubMed

Sponsoren und Mitarbeiter

Krankheiten

Drogeninterventionen

3
Abonnieren